Interferon-β induces S phase accumulation selectively in human transformed cells

Journal of Interferon and Cytokine Research

Volumn 17, Issue 6, 1997, Pages 355-367

  Qin, Xiao Qiang ^a   Runkel, Laura ^a   Deck, Christina ^a   DeDios, Carole ^a   Barsoum, James ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; BETA INTERFERON; GAMMA INTERFERON; RECOMBINANT BETA INTERFERON; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

EID: 0031010777     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.355     Document Type: Article

References (40)

1. LENGYEL, P. (1982). Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51, 251-282.
2. DARNELL, J.E., KERR, I.M., and STARK, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
3. IHLE, J.E., and KERR, I.M. (1995). Jaks and Stats in signalling by the cytokine receptor superfamily. Trends Genet. 11, 69-74.
4. SCHINDLER, C., and DARNELL, J.E. (1995). Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64, 621-651.
5. GREENLUND, A.C., FARRAR, M.A., VIVIANO, B.L., and SCHREIBER, R.D. (1994). Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
6. STAHL, N., FARRUGGELLA, T.J., BOULTON, T.G., ZHONG, Z., DARNELL, J.E., and YANCOPOULOS, G.D. (1995). Choices of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptor. Science 267, 1349-1353.
7. LEUNG, S., QURESHI, S.A., KERR, I.M., DARNELL, J.E., and STARK, G.R. (1995). Role of STAT2 in the alpha interferon signalling pathway. Mol. Cell. Biol. 15, 1312-1317.
8. YAN, H., KRISHNAN, K., GREENLUND, A.C., GUPTA, S., LIM, J.T.E., SCHREIBER, R.D., SCHINDLER, C.W., and KROLEWSKI, J.J. (1996). Phosphorylated interferon-α receptor 1 subunit (IFNAR1) acts as a docking site for the latent form of the 113 kDa Stat2 protein. EMBO J. 15, 1064-1074.
9. XU, X., SUN, Y.-L., and HOEY, T. (1996). Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273, 794-797.
10. 2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15, 5616-5626.
11. 1 arrest. Nature 313, 597-600.
12. KIMCHI, A., RESNITZKY, D., BER, R., and GAT, G. (1988). Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis. Mol. Cell. Biol. 8, 2828-2836.
13. RESNITZKY, D., TIEFENBRUN, N., BERISSI, H., and KIMCHI, A. (1992). Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA 89, 402-406.
14. 0-like arrest. Mol. Cell. Biol. 16, 3934-3944.
15. WEINBERG, R.A. (1991). Tumor suppressor genes. Science 254, 1138-1146.
16. HUANG, H.-J.S., YEE, J.-K., SHEW, J.-Y., CHEN, P.-L., BOOKSTEIN, R., FRIEDMANN, T., LEE, E.Y.-H.P., and LEE, W.-H. (1988). Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563-1566.
17. NEVINS, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
18. LIVINGSTON, D.M. (1992). Functional analysis of the retinoblastoma gene product and of RB-SV40 T antigen complexes. Cancer Surv. 12, 153-160.
19. LA THANGUE, N.B. (1994). DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci. 19, 108-114.
20. MATTSON, K.V., HAND, A.M., and MAASILTA, P.K. (1994). Interferons and lung cancer. In: Lung Cancer. H.H. Hansen (ed.) Kluwer Academic Press, pp. 293-321.
21. OBERG, K. (1992). The action of interferon alpha on human carcinoid tumors. Semin. Cancer Biol. 3, 35-41.
22. WADLER, S., and SCHWARTZ, E.L. (1990). Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res. 50, 3473-3486.
23. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15, 2600-2611.
24. QIN, X.-Q., LIVINGSTON, D.M., EWEN, M., SELLERS, W.R., ARANY, Z., and KAELIN, W.G. (1995). The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15, 742-755.
25. 1 progression. Oncogene 9, 2663-2674.
26. BROWNING, J.L., MIATKOWSKI, K., SIZING, I., GRIFFITHS, D., ZAFARI, M., BENJAMIN, C.D., MEIER, W., and MACKAY, F. (1996). Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183, 867-878.
27. QIN, X.-Q., LIVINGSTON, D.M., KAELIN, W.G., and ADAMS, P.D. (1994). Deregulated transcriptional factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
28. EWEN, M.E., SLUSS, H.K., SHERR, C.J., MATSUSHIME, H., KATO, J-Y., and LIVINGSTON, D.M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
29. ZHU, L., VAN DEN HEUVEL, S., HELIN, K., FATTAEY, A., EWEN, M.E., LIVINGSTON, D.M., DYSON, N., and HARLOW, E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.
30. BUCHKOVICH, K., DUFFY, L.A., and HARLOW, E. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
31. DECAPRIO, J.A., LUDLOW, J.W., LYNCH, D., FURUKAWA, Y., GRIFFIN, J., PIWNICA-WORMS, H., HUANG, C.-M., and LIVINGSTON, D.M. (1989). The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095.
32. CHEN, P., SCULLY, P., SHEW, J.-Y., WANG, J.Y.J., and LEE, W.-H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
33. MIHARA, K., CAO, X.-R., YEN, A., CHANDLER, S., DRISCOLL, B., MURPHREE, A.L., TANG, A., and FUNG, Y.-K.T. (1989). Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303.
34. STEIN, G.H., BEESON, M., and GORDON, L. (1990). Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249, 666-669.
35. 1 phase of the cell cycle. Cell 67, 293-302.
36. PANNIERS, L.R.V., and CLEMENS, M.J. (1981). Inhibition of cell division by interferon: changes in cell cycle characteristics and in morphology of Ehrlich ascites tumor cell in culture. J. Cell Sci. 48, 259-279.
37. GEWERT, D.R., MOORE, G., TILLERAY, V.J., and CLEMENS, M.J. (1984). Inhibition of cell proliferation by interferons: 1. Effects on cell division and DNA synthesis in human lymphoblastoid (Daudi) cells. Eur. J. Biochem. 139, 619-625.
38. MOORE, G., GEWERT, D.R., and CLEMENS, M.J. (1984). Inhibition of cell proliferation by interferons: 2. Changes in processing and stability of newly synthesized DNA in human lymphoblastoid (Daudi) cells. Eur. J. Biochem. 139, 627-635.
39. GENKA, S., SHITARA, N., TSUJITA, Y., KOSUGI, Y., and TAKAKURA, K. (1988). Effect of interferon-β on the cell cycle of human glioma cell line U-251MG: flow cytometric two-dimensional (BrdU/DNA) analysis. J. Neuro-Oncol. 6, 299-307.
40. PREISLER, H.D., GOPAL, V., BANAVALI, S.D., FINKE, D., and BOKARI, S.A.J. (1992). Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents. Cancer Res. 52, 4090-4095.